Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06393062
Other study ID # 2022/7-17
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 1, 2022
Est. completion date September 30, 2024

Study information

Verified date April 2024
Source Adiyaman University
Contact Bedreddin Kalyenci
Phone +905554859583
Email bedreddin84@windowslive.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, investigators compared the systemic inflammatory responses after percutaneous nephrolithotomy (PCNL) patients who were given an expanded empirical antibiotic regimen based on the prediction of the possibility of bacteria identified by Gram staining the first urine after renal puncture and patients whose antibiotic regimen was not performed and whose antibiotic regimen was adjusted according to patient symptoms and culture results. Investigators aimed to test its diagnostic value in predicting and preventing complications.


Recruitment information / eligibility

Status Recruiting
Enrollment 245
Est. completion date September 30, 2024
Est. primary completion date August 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patients with an indication for percutaneous nephrolithotomy due to kidney stone disease. Exclusion Criteria: - under 18 years old, - having an active urinary tract infection before surgery and positive urine cultures, - Patients with bilateral kidney stones, - DJ stent or nephrostomy placement, - Solitary kidney stones, - Bleeding disorders, - impaired kidney function, - a history of antibiotic use for any reason within 2 weeks before randomization were excluded from the study.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Gram staining of the first urine after intraoperative renal puncture to predict the systemic inflammatory response after percutaneous nephrolithotomy.
Gram staining of the first urine after intraoperative renal puncture to predict the systemic inflammatory response after percutaneous nephrolithotomy.

Locations

Country Name City State
Turkey Adiyaman University, Medicine of Faculty Adiyaman

Sponsors (1)

Lead Sponsor Collaborator
Adiyaman University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy of Gram stain in predicting systemic inflammatory response after percutaneous nephrolithotomy. Gram staining of urine after puncture to detect the presence of bacteria that are a possible source of infection according to the rate of gram-stained and non-gram-stained patients by microscopic examination. immediately after the surgery
Secondary Change of antibiotic regimen after bacterial estimation of Gram stain The percentage of patients whose antibiotic regimen was changed by estimating bacteria after Gram staining did not progress to systemic inflammatory response syndrome. Systemic inflammatory response criteria: temperature less than 36 °C or higher than 38 °C, heart rate more than 100 beats per minute, respiratory rate more than 20 per minute, leukocyte count greater than 12 × 10 up 9/L or 4 × 10 up 9/L less than L, systolic blood pressure falling below 90 mmHg, or diastolic blood pressure falling below 40 mmHg immediately after the surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05574517 - Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter N/A
Completed NCT02764008 - The Comparison of Low Thoracic Paravertebral Block Versus Peritubal Infiltration Phase 4
Enrolling by invitation NCT06266793 - Comparison of Holmium Laser and Thulium Laser for Mini PCNL N/A
Recruiting NCT03907930 - Conventional PCNL Versus Tubeless PCNL N/A
Completed NCT05467878 - The Effect of Anesthesia on Pain in Percutaneous Nephrolithotomy
Completed NCT04340037 - Prediction of Sepsis After Percutaneous Nephrolithotomy
Not yet recruiting NCT03178292 - Conventional Antibiotic Prophylaxis Versus Add-On 5 Days Levofloxacin Before Percutaneous Nephrolithotomy N/A
Completed NCT04346134 - Mini- Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy for High Density Renal Stones N/A
Not yet recruiting NCT04943081 - Percutaneous Nephrolithotomy in Patients With Stage 2-4 Chronic Kidney Disease N/A
Not yet recruiting NCT04196270 - The Minimal Effective Volume (MEV90) of Ropivacaine 0.75% for Ultrasound-guided Transmuscular Quadratus Lumborum Block Phase 4
Not yet recruiting NCT03016650 - Opioid-sparing Effect of Intravenous Ibuprofen Phase 4
Completed NCT05855057 - Effectiveness of US-Guided PCNL Different Positions in Renal Stones Treatment
Not yet recruiting NCT05725083 - Lower Thoracic Epidural vs Erector Spinae Block for PNL N/A
Completed NCT05947435 - Tranexamic Acid in Percutaneous Nephrolithotomy N/A
Recruiting NCT05077007 - Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers N/A
Completed NCT03897933 - Erector Spinae Plane Block for Postoperative Pain in Percutaneous Nephrolithotomy Patients: a Retrospective Study
Recruiting NCT05661175 - Application of One-handed Lithotripsy in Percutaneous Nephrolithotomy N/A
Recruiting NCT05012215 - Paravertebral Versus Caudal Block in Pediatric PCNL N/A
Recruiting NCT04856722 - Mini-PNL, RIRS, and ESWL for Treatment of Medium-Sized, High-Density, Non-Lower Pole, Renal Stones N/A
Recruiting NCT04852874 - Quadratus Lumborum Block as an Anesthetic Method for Percutaneous Nephrolithotomy N/A